The Obesity Collective was well represented at the 2026 Australia and New Zealand Obesity Society (ANZOS) Annual Scientific Meeting, held in Brisbane from 21–23 October.
The conference brought together researchers, clinicians, healthcare professionals, advocates and people with lived experience to share knowledge, explore emerging research and discuss the challenges and opportunities shaping the future of obesity care.
A highlight was the opportunity for our Program and Communications Manager, Monica Garner, to join her Weight Issues Network (WIN) colleagues on a panel exploring lived experience and health equity in the context of higher weight and obesity. The discussion provided an opportunity to bring consumer perspectives into conversations about the way people experience healthcare, the barriers they encounter and the importance of equity in how care is understood and delivered.
The Obesity Collective’s Director, Tim Gill, also contributed to the conference through his involvement in chairing sessions and presenting the ANZOS award, reflecting his ongoing role as part of the conference planning team.
ANZOS also provided a valuable opportunity to connect in person with colleagues, researchers, advisors and partners from across the obesity sector. These conversations offered the chance to exchange ideas, strengthen existing relationships and build new connections with people working across research, clinical practice, advocacy and lived experience.
The research presented throughout the meeting was particularly interesting, with growing attention to GLP-1 medications and their place in the evolving landscape of obesity treatment. Alongside discussions about emerging treatments, the importance of comprehensive, wraparound care was also an important consideration. Medications are one part of a person’s care journey, and access to appropriate ongoing support – including clinical monitoring, nutrition, psychological support and individualised care – remains essential. As treatment options continue to evolve, it is important that healthcare approaches look beyond medication alone and support the whole person.
The Obesity Collective was also pleased to share a joint exhibition presence with WIN, creating another opportunity to connect with conference attendees and highlight the work being undertaken across both organisations.
ANZOS 2026 was a valuable few days of learning, discussion and connection. We thank everyone who shared their research, knowledge and perspectives, and look forward to continuing these conversations and collaborations beyond the conference.
